SB 2019

  • Tennessee Senate Bill
  • 113th Regular Session (2023-2024)
  • Introduced in Senate Jan 29, 2024
  • Passed Senate Jan 31, 2024
  • Passed House Apr 11, 2024
  • Signed by Governor Apr 29, 2024

Drugs, Prescription - As enacted, makes changes to the law relative to prescribing buprenorphine products. - Amends TCA Title 33 and Title 53.

Votes


Actions


May 09, 2024

Senate

Effective date(s) 07/01/2024

Senate

Pub. Ch. 808

Apr 29, 2024

Senate

Signed by Governor.

Apr 17, 2024

Senate

Transmitted to Governor for action.

Apr 16, 2024

Senate

Signed by Senate Speaker

House

Signed by H. Speaker

Apr 15, 2024

Senate

Enrolled and ready for signatures

Apr 11, 2024

Senate

Am. withdrawn. (Amendment 1 - HA0850)

Senate

Subst. for comp. HB.

House

Passed H., Ayes 83, Nays 5, PNV 2

Mar 28, 2024

Senate

Rcvd. from S., held on H. desk.

Mar 26, 2024

Senate

Sponsor(s) Added.

Mar 25, 2024

Senate

Senate adopted Amendment (Amendment 1 - SA0702)

Senate

Passed Senate as amended, Ayes 32, Nays 1

Senate

Engrossed; ready for transmission to House

Mar 22, 2024

Senate

Placed on Senate Regular Calendar for 3/25/2024

Mar 13, 2024

Senate

Sponsor(s) Added.

Senate

Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 8, Nays 1 PNV 0

Mar 06, 2024

Senate

Placed on Senate Health and Welfare Committee calendar for 3/13/2024

Jan 31, 2024

Senate

Passed on Second Consideration, refer to Senate Health and Welfare Committee

Jan 29, 2024

Senate

Introduced, Passed on First Consideration

Jan 25, 2024

Senate

Filed for introduction

Bill Text

Bill Text Versions Format
Current Version PDF
Amendment SA0702 PDF
Amendment HA0850 PDF

Related Documents

Document Format
Fiscal Memo for SA0702 (15859)
Fiscal Note

Sources

Data on Open States is updated periodically throughout the day from the official website of the Tennessee General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.